Phase IV Clinical Study of the Safety of Menhycia in 3-Month-Old Infants
Latest Information Update: 05 Jul 2024
At a glance
- Drugs Meningococcal vaccine groups A C Y W-135 conjugate (Primary)
- Indications Meningitis
- Focus Adverse reactions
- Sponsors Tianjin CanSino Biotechnology
- 24 Jun 2024 Status changed from not yet recruiting to recruiting.
- 07 May 2024 New trial record